featured
Etoposide and Cisplatin vs Irinotecan and Cisplatin for Advanced Neuroendocrine Carcinoma of the Digestive System
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System: The TOPIC-NEC Phase 3 Randomized Clinical Trial
JAMA Oncol 2022 Aug 18;[EPub Ahead of Print], C Morizane, N Machida, Y Honma, T Okusaka, N Boku, K Kato, S Nomura, N Hiraoka, S Sekine, H Taniguchi, N Okano, K Yamaguchi, T Sato, M Ikeda, N Mizuno, M Ozaka, T Kataoka, M Ueno, Y Kitagawa, M Terashima, J FuruseFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.